
News|Articles|December 24, 2024
RECAP: 2024 Updates in the GLP-1 Space
Key Takeaways
Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How the Chai Discovery–Eli Lilly Collaboration Could Advance the Future of AI-Driven Biologics Development
2
Peptide Therapy for Weight Loss: Separating Clinical Promise From Social Media Hype
3
First-Ever Guideline on Cardio-Kidney-Metabolic Syndrome Calls for Earlier Screening, Coordinated Care
4
Apixaban vs Rivaroxaban: A Clearer Choice for VTE?
5



































































































































